1. Home
  2. PRPO vs APLT Comparison

PRPO vs APLT Comparison

Compare PRPO & APLT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Precipio Inc.

PRPO

Precipio Inc.

N/A

Current Price

$24.67

Market Cap

32.4M

Sector

Industrials

ML Signal

N/A

Logo Applied Therapeutics Inc.

APLT

Applied Therapeutics Inc.

HOLD

Current Price

$0.11

Market Cap

38.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PRPO
APLT
Founded
N/A
2016
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Laboratory Analytical Instruments
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
32.4M
38.1M
IPO Year
N/A
2019

Fundamental Metrics

Financial Performance
Metric
PRPO
APLT
Price
$24.67
$0.11
Analyst Decision
Hold
Analyst Count
0
3
Target Price
N/A
$1.25
AVG Volume (30 Days)
14.5K
27.2M
Earning Date
11-14-2025
11-13-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$22,800,000.00
$1,000,000.00
Revenue This Year
N/A
$124.18
Revenue Next Year
N/A
$66.67
P/E Ratio
N/A
N/A
Revenue Growth
30.95
N/A
52 Week Low
$3.90
$0.11
52 Week High
$28.50
$1.50

Technical Indicators

Market Signals
Indicator
PRPO
APLT
Relative Strength Index (RSI) 56.64 25.08
Support Level $23.92 $0.21
Resistance Level $25.62 $0.26
Average True Range (ATR) 1.34 0.02
MACD -0.09 0.01
Stochastic Oscillator 66.75 6.69

Price Performance

Historical Comparison
PRPO
APLT

About PRPO Precipio Inc.

Precipio Inc is a healthcare solutions company focused on cancer diagnostics. It focuses on addressing the problem of cancer misdiagnoses by developing solutions to mitigate the root causes of this problem in the form of diagnostic products, reagents, and services. The company operates Clinical Laboratory Improvement Amendments laboratories in both the New Haven, Connecticut and Omaha, Nebraska locations providing essential blood cancer diagnostics to office-based oncologists in many states nationwide. It provides new technologies to the oncology diagnostic laboratory market in the form of HemeScreen and IV-Cell product offerings. The company generates the majority of its revenue from third-party payers.

About APLT Applied Therapeutics Inc.

Applied Therapeutics Inc is a clinical-stage biopharmaceutical company, developing a pipeline of novel product candidates against validated molecular targets in indications of high unmet medical need. The company's drug compounds pipeline includes AT-007 which is a novel central nervous system, penetrant ARI that it is developing for the treatment of rare metabolic diseases, including Galactosemia and Sorbitol Dehydrogenase (SORD) Deficiency, AT-001 for the treatment of diabetic cardiomyopathy, and AT-003 for the treatment of diabetic retinopathy.

Share on Social Networks: